Literature DB >> 20061577

Successful termination of a ventricular arrhythmia by implantable cardioverter defibrillator therapy in a patient with cardiac amyloidosis: insight into mechanisms of sudden death.

Grace Lin1, Angela Dispenzieri, Peter A Brady.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20061577     DOI： 10.1093/eurheartj/ehp592

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  6 in total

Review 1.  Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs.

Authors:  Adam Castaño; Brian M Drachman; Daniel Judge; Mathew S Maurer
Journal:  Heart Fail Rev       Date:  2015-03       Impact factor: 4.214

Review 2.  Natural history and therapy of AL cardiac amyloidosis.

Authors:  Martha Grogan; Angela Dispenzieri
Journal:  Heart Fail Rev       Date:  2015-03       Impact factor: 4.214

3.  Life-saving implantable cardioverter defibrillator therapy in cardiac AL amyloidosis.

Authors:  Ketna S Patel; Philip N Hawkins; Carol J Whelan; Julian D Gillmore
Journal:  BMJ Case Rep       Date:  2014-12-22

Review 4.  Clinical management of amyloid cardiomyopathy.

Authors:  Morris M Kim; Clinton M Kolseth; Dayna Carlson; Ahmad Masri
Journal:  Heart Fail Rev       Date:  2021-09-01       Impact factor: 4.654

5.  Trends, burden, and impact of arrhythmia on cardiac amyloid patients: A 16-year nationwide study from 1999 to 2014.

Authors:  Ameesh Isath; Ashish Correa; Gregory P Siroky; Stuthi Perimbeti; Selma Mohammed; C Anwar A Chahal; Deepak Padmanabhan; Davendra Mehta
Journal:  J Arrhythm       Date:  2020-06-11

Review 6.  Diagnosis and treatment of cardiac amyloidosis: position statement of the German Cardiac Society (DGK).

Authors:  A Yilmaz; J Bauersachs; F Bengel; R Büchel; I Kindermann; K Klingel; F Knebel; B Meder; C Morbach; E Nagel; E Schulze-Bahr; F Aus dem Siepen; N Frey
Journal:  Clin Res Cardiol       Date:  2021-01-18       Impact factor: 5.460
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.